News
Media
Between the LinesExpert InterviewsK-CastMedical World NewsPodcastsPopulation Health Perspectives
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
Webinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory

Subscribe

  • News
  • Media
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Subscribe
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Diabetes
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pain
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
Spotlight -
AMCP Nexus 2025|
2025 Fall Clinical Dermatology|
AAO 2025|
PBMI 2025|
ASRS 2025|
Between the Lines: Diving Deeper Into the EMERALD Trial
Advertisement

Thomas Nusbickel, Chief Commercial Officer, Celltrion USA

Advertisement

Articles by Thomas Nusbickel, Chief Commercial Officer, Celltrion USA

Celltrion USA is Committed to Delivering Advancements in IBD Treatments

ByThomas Nusbickel, Chief Commercial Officer, Celltrion USA
November 6th 2023
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Managed Healthcare Executive

    1

    A Potential First-in-Class Treatment Shows Improvement in a Rare Type of Narcolepsy

    2

    Fulton County Leaders Discuss Closing Health Gaps and Strengthening Behavioral Health Systems

    3

    Tubeless AID Systems Boost HRQoL in Type 1 Diabetes

    4

    Nonstatin Therapies and the Future of CVD Risk Reduction

    5

    Tackling Health Inequities Through Collaboration and Community-Based Care

    • About Us
    • Advertise
    • Editorial
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    • Formulary Watch
    • Pharmacy Benefit Management Institute
    Managed Healthcare Executive
    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us